Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...

Berenberg analyst Luisa Hector lowered the firm’s price target on Merck (MRK) to $115 from $125 and keeps a Buy rating on the shares. Merck ...

Heading into the 2025 season, the Louisville Bats will have a new logo that draws on the history of the franchise and the legacy of where they play - Louisville ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks for 2025. The Magic Formula, as defined by Joel Greenblatt in his ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Craig-Hallum analyst Jeremy Hamblin maintained a Buy rating on Ollie’s Bargain Outlet Holding (OLLI – Research Report) today. The company’s ...

The SAG Awards will stream live on Netflix on Sunday, Feb. 23, 2025 at 8 p.m. ET / 5 p.m. PT. Scroll through the gallery for up-to-date photos from the SAG red carpet.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis' JAKAFI ...